THEY SAID IT! E&C Lawmakers Pledge Bipartisan Action To Boost Transparency, Hold Big Pharma Accountable & Lower Drug Prices
May 22, 2019
Washington, D.C. – The U.S. House Energy & Commerce Subcommittee on… Read More
© 2025 CSRXP- All Rights Reserved
They Said It
THEY SAID IT! House Energy & Commerce Lawmakers Roast Big Pharma, Pledge Bipartisan Action and Question the Rebate Rule
May 10, 2019
Washington, D.C. – The House Energy & Commerce Subcommittee on Health… Read More
THEY SAID IT! Lawmakers Vow Action To Lower Insulin Prices & Criticize Pharma For Price-Gouging, Blame Game
Apr 11, 2019
Today, the U.S. House Committee on Energy and Commerce Subcommittee on… Read More
THEY SAID IT! Lawmakers Blast Insulin Price Hikes, Call For Drug Price Action And Question The Rebate Rule
Apr 3, 2019
On Tuesday, the U.S. House Committee on Energy and Commerce Subcommittee on… Read More
They Said It! Lawmakers Advance Key Drug Pricing Bills
Mar 28, 2019
House Energy & Commerce Members Recommit To Bipartisan Action As Critical… Read More
THEY SAID IT! U.S. House Ways & Means Subcommittee Pushes For Increased Competition To Lower Drug Prices
Mar 8, 2019
On Thursday, members of the U.S. House Committee on Ways and Means… Read More
THEY SAID IT! Senators On Aging Committee Join Call For Action In Washington To Alleviate Rising Burden Of Prescription Drug Prices
Mar 6, 2019
On Wednesday, five American patients gave eye-opening testimony to members of… Read More
They Said It: Senators Slam Big Pharma CEOs For Price Gouging, Anti-Competitive Tactics
Feb 27, 2019
On Tuesday, the U.S. Senate Committee on Finance held its second hearing on… Read More
They Said It! House Lawmakers Agree Bipartisan Action Needed To Bring Down Drug Prices
Feb 13, 2019
On Tuesday, the U.S. House Committee on Ways & Means held the third… Read More
THEY SAID IT! Drug Companies Have Been Warned
Jan 31, 2019
Drug Companies Have Been Warned: House & Senate Chairmen & Ranking… Read More
CSRxP Introduces Proposals for Change
Apr 27, 2016
The Campaign for Sustainable Rx Pricing (CSRxP) kicked off the week with the introduction of its new policy platform aimed to curb skyrocketing prescription drug prices through increased transparency and competition which results in value. CSRxP’s solutions come at a critical time in the conversation about drug pricing, as this bipartisan issue garners unprecedented attention among policymakers, voters, and presidential candidates. Read More
One Thing Presidential Candidates Can Agree On
Mar 1, 2016
Seven presidential candidates are still in the race heading into Super Tuesday and all of them are talking about rising prescription drug prices. While they differ in their solutions to this epidemic, candidates on both sides of the aisle agree that drug prices are rising at an unsustainable rate. Read More